Stockscreener 앱 받기
30.09
1.44%
-0.44
시간 외 거래:
29.99
-0.10
-0.33%
전일 마감가:
$30.53
열려 있는:
$30.81
하루 거래량:
1.27M
Relative Volume:
0.87
시가총액:
$1.92B
수익:
-
순이익/손실:
$-107.85M
주가수익비율:
-13.62
EPS:
-2.21
순현금흐름:
$-106.82M
1주 성능:
-0.17%
1개월 성능:
+23.52%
6개월 성능:
+37.96%
1년 성능:
-25.15%
1일 변동 폭
$29.41
$30.81
1주일 범위
$29.41
$31.80
52주 변동 폭
$18.53
$51.61
베라 테라 Stock (VERA) Company Profile
명칭
Vera Therapeutics Inc
전화
650-770-0077
주소
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
VERA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
30.09 | 1.95B | 0 | -107.85M | -106.82M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
베라 테라 Stock (VERA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-04 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | 재개 | H.C. Wainwright | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2025-01-28 | 개시 | Goldman | Buy |
| 2024-11-21 | 개시 | Wells Fargo | Overweight |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-01-25 | 개시 | Oppenheimer | Outperform |
| 2024-01-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-12-18 | 개시 | Raymond James | Outperform |
| 2023-11-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-16 | 개시 | Guggenheim | Buy |
| 2023-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-01-04 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-07-12 | 개시 | JP Morgan | Overweight |
| 2022-05-02 | 개시 | H.C. Wainwright | Buy |
| 2022-04-19 | 개시 | Wedbush | Outperform |
모두보기
베라 테라 주식(VERA)의 최신 뉴스
Trend analysis for Vera Therapeutics Inc. this weekTrade Risk Report & Community Consensus Stock Picks - newser.com
Detecting support and resistance levels for Vera Therapeutics Inc.2025 Dividend Review & Fast Entry Momentum Alerts - newser.com
Why Vera Therapeutics Inc. stock could rally in 2025July 2025 Outlook & Daily Chart Pattern Signals - newser.com
Vera Therapeutics' (VERA) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Polycythemia Vera Pipeline 2025: FDA Updates, Therapy - openPR.com
What indicators show strength in Vera Therapeutics Inc.Portfolio Gains Summary & Technical Pattern Alert System - newser.com
Using RSI to spot recovery in Vera Therapeutics Inc.2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Heatmap analysis for Vera Therapeutics Inc. and competitorsBear Alert & AI Powered Buy and Sell Recommendations - newser.com
Will Vera Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com
Is Vera Therapeutics Inc. stock overvalued by current metricsOptions Play & Free Growth Oriented Trading Recommendations - newser.com
Risk vs reward if holding onto Vera Therapeutics Inc.2025 Top Gainers & High Accuracy Swing Trade Signals - newser.com
J. Safra Sarasin Holding AG Takes Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Evaluating Vera Therapeutics Inc. with trendline analysisJuly 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com
Developing predictive dashboards with Vera Therapeutics Inc. dataJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - newser.com
What drives Vera Therapeutics Inc stock priceLong-Term Growth Stocks & These Stocks Are Just Getting Started - earlytimes.in
Evercore Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $75 - 富途牛牛
Vera Therapeutics, Inc. $VERA Shares Purchased by Platinum Investment Management Ltd. - MarketBeat
13,567 Shares in Vera Therapeutics, Inc. $VERA Acquired by GC Wealth Management RIA LLC - MarketBeat
Fifth Third Bancorp Buys New Stake in Vera Therapeutics, Inc. $VERA - Defense World
10,406 Shares in Vera Therapeutics, Inc. $VERA Purchased by Perigon Wealth Management LLC - MarketBeat
J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating - 富途牛牛
What analysts say about Vera Therapeutics Inc stockDividend Reinvestment Plans & Low Risk Investment Tips - earlytimes.in
Vera Therapeutics Inc Stock Analysis and ForecastHigh Beta Stocks & Small Entry Investment Ideas - Early Times
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Vera Therapeutics (NASDAQ:VERA) Shares Up 5.3%Time to Buy? - MarketBeat
Vera Therapeutics (VERA): Assessing Valuation After New KDIGO Guidelines Shape the IgA Nephropathy Market - Sahm
Vera Therapeutics, Inc. (VERA) Stock Analysis: Unpacking A 140% Potential Upside - DirectorsTalk Interviews
LifeSci Capital Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $70 - 富途牛牛
Is Vera Therapeutics (VERA) Positioned to Benefit Most from Expanding IgA Nephropathy Treatment Guidelines? - Sahm
Pullback Watch: Is Vera Therapeutics Inc stock overvalued or fairly pricedJuly 2025 EndofMonth & Fast Momentum Stock Entry Tips - khodrobank.com
Voya Investment Management LLC Has $15.07 Million Holdings in Vera Therapeutics, Inc. $VERA - MarketBeat
Dow Update: How correlated is Vera Therapeutics Inc to the S P5002025 Volume Leaders & Daily Profit Maximizing Trade Tips - خودرو بانک
Dynamic Technology Lab Private Ltd Takes $326,000 Position in Vera Therapeutics, Inc. $VERA - MarketBeat
What technical models suggest about Vera Therapeutics Inc.’s comeback2025 Top Gainers & Real-Time Market Trend Scan - newser.com
Panic Selling: Is Baidu Inc. Depositary Receipt forming a double bottomMarket Risk Summary & Low Risk Profit Maximizing Plans - خودرو بانک
베라 테라 (VERA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
베라 테라 주식 (VERA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ENRIGHT PATRICK G | Director |
Jun 24 '25 |
Buy |
22.35 |
40,607 |
907,635 |
3,596,593 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 21 '25 |
Sale |
27.89 |
10,613 |
296,032 |
213,740 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 26 '25 |
Sale |
27.65 |
9,075 |
250,882 |
204,665 |
5.74%
자본화:
|
볼륨(24시간):